CytoReason and Ferring Pharmaceuticals announced a collaboration that pairs CytoReason’s artificial intelligence (AI)-based computational model of the human body with Ferring’s expertise in inflammatory bowel disease (IBD). The purpose is to develop cell-based disease models to accelerate drug discovery and reduce development costs.
In a groundbreaking study, scientists at Harvard University identified an enzyme that seems to dictate the limits of human physical performance.
Coronavirus Transmission: Where the Virus Goes in the Body and How SARS-CoV-2 is Spread
ACE2 (angiotensin-converting enzyme-2), Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Dr. Anthony Fauci (Director), Human Body, Medical Journals, National Institute of Allergy and Infectious Diseases (NIAID), R&D, Researchers, Science, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Lancet, World Health OrganizationA look at which parts of the body the novel coronavirus infects and how SARS-CoV-2 is transmitted from person to person.
Nearly a dozen approved drugs could be effective against COVID-19: study
Antihistamines, Antimalarial, Antipsychotics, Antivirals, Cancer Therapies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Donald Trump, Drug Compounds, France, Heart tissue, Human Body, Hydroxychloroquine, Proteins, R&D, Remdesivir, Scientists, Studies, United StatesAt least 10 different drug compounds ranging from cancer therapies to antipsychotics and antihistamines may be effective at preventing the new coronavirus from multiplying in the body, according to a multidisciplinary study conducted by a team of scientists in the United States and France.
Results from NASA’s landmark Twins Study reveals some interesting, surprising and reassuring data.